Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

A new drug for people who have one of the worst forms of multiple sclerosis aims to make treatment much easier for patients. Ocrevus is a medicine commonly used to treat primary progressive MS ...

BNAC’s strongly patient-driven Advisory Council convinced Zivadinov and colleagues to consider studying this rare form of MS. The council’s chair, Larry Montani, had watched two of his siblings ...

20. Another Phase III study known as PERSEUS in another progressive form of MS is still ongoing, with results expected in 2025, Sanofi added. The French group is also working on MS candidate ...

Experts aren’t sure what causes multiple sclerosis, but they have identified four primary risk factors that may interact with each other: immune system malfunction, genetics, environmental ...

The study involved 334 kids and young adults, ages 4 to 21, who had all developed a childhood form of MS within four years of enrolling in the study. Their symptoms were tracked for a median of 3. ...